Navigation Links
DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two million Americans are affected each year by DVT, with up to 600,000 hospitalized. Its primary complication, pulmonary embolism (PE), claims up to 300,000 lives annually -- more than breast cancer and AIDS combined. People who suffer from cardiovascular disease may be at increased risk for DVT, because these factors also heighten the likelihood of blood clots and pooling. Respiratory tract infection may increase risk of blood clots and is associated with inflammation, which may affect the proper functioning of arteries and veins.

The Coalition to Prevent Deep-Vein Thrombosis (DVT) recently sponsored an online survey of a nationally representative sample of consumers and physicians. The survey, which was conducted by Penn, Schoen & Berland Associates, assessed what Americans know about DVT.

The survey results point to an ongoing need for patients and physicians alike to know more about this leading cause of death and how they can reduce the risk of DVT. Following are the results specific to respiratory disease.

    Heart/respiratory patients recognize the significance of heart disease as

    a risk factor for DVT but incorrectly view pulmonary/respiratory disease

    as a much less significant threat.

       * 60% of heart/respiratory patients rate cardiac issues (e.g., heart

         disease, heart attack, arteriosclerosis or CHF) as very significant

         risk factors for DVT.

       * Only 35% see pulmonary/respiratory disease (e.g., asthma, COPD or

         emphysema) as a very significant risk factor.


    Even though they are at greater risk for DVT, heart/respiratory patients

    know only as much about it as the general population.

       * 52% of heart/respiratory patients have some knowledge about DVT -- on

         par with the general population (51%).

       * 40% of heart/respiratory patients have heard or read about DVT

         recently, the same percent
age as in the general population.


    Heart/respiratory patients who know something about DVT are no more likely

    than the general population to recognize key facts about the condition.

       * 17% of heart/respiratory patients correctly identify DVT as a blood

         clot, the same percentage as in the general population.

       * 17% recognize that DVT is a dangerous condition, one that can cause

         stroke or heart attack, or one that can be fatal.


    Despite their greater risk, heart/respiratory patients are no more likely

    than the general population to have discussed DVT with their physicians.

       * 10% of heart/respiratory patients report that their primary care

         physician has discussed DVT with them, compared with 12% of the

         general population.

       * 55% of heart/respiratory patients say that they are likely to ask

         their physicians for DVT information, vs. 50% of the general

         population.

The Coalition to Prevent Deep-Vein Thrombosis is funded by sanofi-aventis U.S. LLC

US.ENO.07.01.122

CONTACT: Shannon McIntyre, +1-212-614-4351

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Survey Reveals Significant Public Lack of Diabetes Awareness
2. DVT Awareness Survey Findings for Respondents in High-Risk Groups: Obese Individuals
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
5. Waismann Method Survey Reveals Dependency Risk for People Using Suboxone
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
8. New Survey Finds Troubling Data on American Asthma Sufferers
9. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
10. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
11. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016 AAIPharma Services Corp./Cambridge Major Laboratories, ... and development services for the pharmaceutical and biotechnology ... capacity in its Charleston, SC ... several recent investments. Charleston ... line with small-scale lyophilization. The site has invested ...
(Date:2/11/2016)... ANKENY, Iowa , 11 de fevereiro de ... a inauguração de sua fábrica de soroalbumina bovina ... Nova Zelândia. A fábrica fica na Ilha Norte ... Loop "), desenvolvido e estabelecido na fábrica da ... Iowa . O projeto e instalação dos ...
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets ... (APAC) breast cancer market will experience considerable expansion ... at a Compound Annual Growth Rate (CAGR) of 8.5%. ... - states that the Asia-Pacific ... billion in 2014 to $3.4 billion by 2021, at a ...
Breaking Medicine Technology:
(Date:2/12/2016)... , ... February 12, 2016 , ... Donor Network West, ... California and Nevada, announced a partnership with San Ramon Regional Medical Center. Under the ... hospital’s facilities as a way to accommodate a more certain time frame for donor ...
(Date:2/12/2016)... TX (PRWEB) , ... February 12, 2016 , ... ... of southwest Houston and surrounding communities by continuing it’s commitment to act as ... Family Promise. The organization works closely with area homeless families to fulfill immediate ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... Strategies for Health Plans and PBMs,” an upcoming Feb. 24 webinar that will ... access in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi ...
(Date:2/12/2016)... ... February 12, 2016 , ... A lot has been ... years. A president has access to health and wellness resources most Americans could ever ... no single individual has a schedule as frenetic as the U.S. President. , ...
(Date:2/12/2016)... ... February 12, 2016 , ... The aging population ... of long term care. With that, says Patrick Loughney, president of Longtree ... roles in long term care environments. His company, which offers prep courses and ...
Breaking Medicine News(10 mins):